Table 2 Various outcomes for referrals to AMD services.

From: The Royal College of Ophthalmologists Commissioning guidelines on age macular degeneration: executive summary

Outcome

Action

No AMD

Discharge

Early AMD

Follow recommendations for early AMD care pathway

Late indeterminate AMD

Monitoring with visual acuity and OCT assessment; treatment initiated if nAMD is confirmed

nAMD present and symptomatic presenting VA better 6/96 or better

Follow the recommendation for nAMD care pathway

nAMD with or without disciform scar and poor visual potential (presenting visual acuity Snellen 6/96 or worse or ETDRS letters less than 25 letters)

Clinicians’ discretion to initiate treatment or monitor. NICE guidance advises only consider treatment if the patient’s visual function could improve, e.g., if the better-seeing eye is affected. Discharge if no treatment is expected. Refer to support services if indicated

Geographic atrophy (late dry AMD)

Follow recommendations for late dry AMD care pathway

Non-AMD causes fluid at macula

Referral to Medical or Surgical Retina Service for diagnosis confirmation and appropriate treatment

Other pathology

Refer to subspecialty depending on pathology identified

  1. AMD age-related macular degeneration, ETDRS early treatment diabetic retinopathy study, nAMD neovascular age-related macular degeneration, NICE National Institute for Health and Care Excellence, OCT optical coherence tomography.